ursodeoxycholic acid has been researched along with Necrotizing Enterocolitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gül, A; Sönmezgöz, E; Takci, S; Uysal, M | 1 |
Brodlie, S; Carroll, J; Cowles, RA; Harren, PA; Jan, DM; Lobritto, SJ; Martinez, M; Ventura, KA | 1 |
2 other study(ies) available for ursodeoxycholic acid and Necrotizing Enterocolitis
Article | Year |
---|---|
Ursodeoxycholic acid protects neonatal rats from necrotizing enterocolitis: a biochemical, histopathological, and immunohistochemical study.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Enterocolitis, Necrotizing; Rats; Ursodeoxycholic Acid | 2021 |
Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Topics: Bilirubin; Biomarkers; Child; Child, Preschool; Cholestasis, Intrahepatic; Enteral Nutrition; Enterocolitis, Necrotizing; Fat Emulsions, Intravenous; Gastrointestinal Motility; Humans; Infant; Infant, Newborn; Infant, Premature; Intestinal Diseases; Intestinal Obstruction; Intestine, Small; Intestines; Liver Diseases; Organ Transplantation; Parenteral Nutrition; Patient Care Team; Postoperative Complications; Referral and Consultation; Rehabilitation Centers; Short Bowel Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2010 |